Ropes & Gray represented FibroGen, Inc. in the transaction. FibroGen, Inc. (NASDAQ: FGEN) announced the sale of its China subsidiary, Fibrogen China, to AstraZeneca for approximately...
You must be a Standard 1 Year member to access this content.
Ropes & Gray and Willkie Farr & Gallagher are serving as legal advisors to Xerox. Dechert LLP is serving as legal advisor to Lexmark, as well...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Zai Lab Limited in the offering, while Simpson Thacher & Bartlett represented the underwriters. Zai Lab Limited (“Zai Lab” or the “Company”)...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Kailera Therapeutics, Inc. on the transaction. Kailera Therapeutics, Inc. (“Kailera”) announced raising $400 million in Series A financing. Kailera announced its launch...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Bain Capital Life Sciences in the transaction. Serán Bioscience (“Serán”), a leading contract development and manufacturing organization (CDMO), announced a strategic growth...
You must be a Standard 1 Year member to access this content.
